Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001435461 | SCV001638284 | likely benign | not provided | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001435461 | SCV001942412 | benign | not provided | 2021-04-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001435461 | SCV004123915 | benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | CACNA1E: BS1, BS2 |
Genome- |
RCV003458704 | SCV004179691 | likely benign | Developmental and epileptic encephalopathy, 69 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001435461 | SCV005258223 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003938757 | SCV004752178 | likely benign | CACNA1E-related disorder | 2019-06-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |